Knowledge Gate Group ApS
Nøgletal
- Afkastningsgrad
- -84,7 %
- Egenkapitalforrentning
- –
- Likviditetsgrad
- 22,6 %
- Soliditetsgrad
- -403,8 %
Resultat
| Regnskabsperiode | |
|---|---|
Bruttoresultat | 4.164.597 |
Driftsresultat | -2.987.465 |
Finansielle indtægter | 644 |
Årets resultat | -3.721.347 |
Medarbejdere
| Regnskabsperiode | |
|---|---|
Gns. ansatte | 7 |
Personaleomkostninger | 6.771.920 kr. |
Balance
| Regnskabsperiode | |
|---|---|
Likvider | 294.855 |
Kortfristede aktiver | 2.158.779 |
Langfristede aktiver | 1.370.327 |
Aktiver i alt | 3.529.106 |
Egenkapital | -14.249.597 |
Forpligtelser i alt | 17.778.703 |
Kortfristede forpligtelser | 9.549.705 |
Arbejdskapital
| Regnskabsperiode | |
|---|---|
Tilgodehavender fra salg og tjenesteydelser | 1.839.958 |
Andre kortfristede tilgodehavender | 0 |
Leverandørgæld | 115.370 |
Kapital og udbytte
| Regnskabsperiode | |
|---|---|
Selskabskapital | 45.789 |
Overført resultat | -15.251.610 |
Investeringer og aktiver
| Regnskabsperiode | |
|---|---|
Langfristede investeringer og tilgodehavender | 144.400 |
Materielle anlægsaktiver | 0 |
Højdepunkter fra årsrapporten
Forretning og udvikling
The company's activity consists of running a business that connects life science companies with experts via a proprietary platform for advisory services (micro-consultations). Included within this is the development and sale of access to the associated software in relation to knowledge sharing.
Development in activities and finances
The year's result shows a deficit of DKK 3,721,735. The management considered the result to be unsatisfactory, but as expected as a result of the company's growth journey. The company's equity is lost. Management is aware of the capital loss rules in Section 119 of the Companies Act. During 2024/25 the company spent significant resources on further developing their market position for local Danish as well as foreign markets. In 2024/25, the company has proven itself in establishing itself as a competitive provider in the market of providing life science companies access to experts worldwide and has had an inceasing activity. During 2025/26 the management has succeeded in raising capital for expenses. This has been done via loans from externa…
Risici og væsentlige forhold
The year's result shows a deficit of DKK 3,721,735. The management considered the result to be unsatisfactory, but as expected as a result of the company's growth journey. The company's equity is lost. Management is aware of the capital loss rules in Section 119 of the Companies Act. During 2024/25 the company spent significant resources on further developing their market position for local Danish as well as foreign markets. In 2024/25, the company has proven itself in establishing itself as a competitive provider in the market of providing life science companies access to experts worldwide and has had an inceasing activity. During 2025/26 the management has succeeded in raising capital for expenses. This has been done via loans from external lenders. The management expects a lo…
No events have occurred after the balance sheet date to this date, which would influence the evaluation of this annual report.
Forpligtelser og sikkerhedsstillelser
The Entity participates in a Danish joint taxation arrangement where Athena Holding ApSserves as the administration company. According to the joint taxation provisions of the Danish Corporation Tax Act, the Entity istherefore liable for income taxes etc for the jointly taxed entities, and for obligations, if any, relating to the withholding of tax on interest, royalties and dividend for the jointly taxed entities.
13 Assets charged and collateral
A company mortgage with a principal of DKK 1,500,000. is provided as security for Vækstfonden (EIFO). The corporate pledge includes intangible assets, receivables from sales and services and property, plant and equipment at a total value of DKK 3,867,484.
Se op til 9 års regnskabshistorik ved at oprette en gratis bruger
Opret gratis bruger